featured
Efficacy and Safety of Sildenafil Added to Pirfenidone in Patients With Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Sildenafil Added to Pirfenidone in Patients With Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension: A Double-Blind, Randomised, Placebo-Controlled, Phase 2b Trial
Lancet Respir Med 2020 Aug 18;[EPub Ahead of Print], J Behr, SD Nathan, WA Wuyts, N Mogulkoc Bishop, DE Bouros, K Antoniou, J Guiot, MR Kramer, KU Kirchgaessler, M Bengus, F Gilberg, A Perjesi, S Harari, AU WellsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.